Susquehanna International Group
CNTB

Susquehanna International Group’s Connect Biopharma Holdings CNTB Stock Holding History

Susquehanna International Group’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$730K Buy
278,808
+207,305
+290% +$540K ﹤0.01% 8709
2025
Q4 		$202K Buy
71,503
+57,755
+420% +$123K ﹤0.01% 10861
2025
Q3 		$20.3K Buy
+13,748
New +$24.3K ﹤0.01% 12050
2023
Q3 		– Sell
-10,470
Closed -$11.6K – 12111
2023
Q2 		$11.6K Sell
10,470
-10,200
-49% -$11.4K ﹤0.01% 11737
2023
Q1 		$20.7K Sell
20,670
-265
-1% -$289 ﹤0.01% 12043
2022
Q4 		$18.2K Buy
+20,935
New +$17.2K ﹤0.01% 11791
2022
Q3 		– Sell
-13,110
Closed -$11K – 13265
2022
Q2 		$11K Buy
+13,110
New +$19.3K ﹤0.01% 12490
2022
Q1 		– Sell
-16,212
Closed -$68.4K – 13082
2021
Q4 		$83K Buy
+16,212
New +$180K ﹤0.01% 12260

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Susquehanna International Group's CNTB Position: Q1 2026 in Review

Susquehanna International Group increased its Connect Biopharma Holdings (CNTB) stake by 290% in Q1 2026, buying an estimated $540K and bringing the position to 278,808 shares worth $730K. The position accounts for ﹤0.01% of the portfolio, ranked #8709.

Susquehanna International Group first reported a position in CNTB in Q4 2021 and has held it in 8 quarters since. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Susquehanna International Group held 278,808 shares of Connect Biopharma Holdings worth $730K as of Q1 2026.
  • Susquehanna International Group bought 207,305 Connect Biopharma Holdings shares in Q1 2026, an estimated $540K.
  • Connect Biopharma Holdings made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8709 holding.
  • Susquehanna International Group first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 8 quarters since.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.